Centre Hospitalier Universitaire de Nantes, Nantes Cedex, France.
University of Calgary, Calgary, Alberta, Canada.
JAMA Neurol. 2019 Apr 1;76(4):405-411. doi: 10.1001/jamaneurol.2018.4510.
Reperfusion is a key factor for clinical outcome in patients with acute ischemic stroke (AIS) treated with endovascular thrombectomy (EVT) for large-vessel intracranial occlusion. However, data are scarce on the association between the time from onset and reperfusion results.
To analyze the rate of reperfusion after EVT started at different intervals after symptom onset in patients with AIS.
DESIGN, SETTING, AND PARTICIPANTS: We conducted a meta-analysis of individual patient data from 7 randomized trials of the Highly Effective Reperfusion Using Multiple Endovascular Devices (HERMES) group. This is a multicenter cohort study of the intervention arm of randomized clinical trials included in the HERMES group. Patients with anterior circulation AIS who underwent EVT for M1/M2 or intracranial carotid artery occlusion were included. Each trial enrolled patients according to its specific inclusion and exclusion criteria. Data on patients eligible but not enrolled (eg, refusals or exclusions) were not available. All analyses were performed by the HERMES biostatistical core laboratory using the pooled database. Data were analyzed between December 2010 and April 2015.
Successful reperfusion was defined as a modified thrombolysis in cerebral infarction score of 2b/3 at the end of the EVT procedure adjusted for age, occlusion location, pretreatment intravenous thrombolysis, and clot burden score and was analyzed in relation to different intervals (onset, emergency department arrival, imaging, and puncture) using mixed-methods logistic regression.
Among the 728 included patients, with a mean (SD) age of 65.4 (13.5) years and of whom 345 were female (47.4%), decreases in rates of successful reperfusion defined as a thrombolysis in cerebral infarction score of 2b/3 were observed with increasing time from admission or first imaging to groin puncture. The magnitude of effect was a 22% relative reduction (odds ratio, 0.78; 95% CI, 0.64-0.95) per additional hour between admission and puncture and a 26% relative reduction (odds ratio, 0.74; 95% CI, 0.59-0.93) per additional hour between imaging and puncture.
Because the probability of reperfusion declined significantly with time between hospital arrival and groin puncture, we provide additional arguments for minimizing the intervals after symptom onset in anterior circulation acute ischemic stroke.
对于接受血管内血栓切除术 (EVT) 治疗的大血管颅内闭塞的急性缺血性脑卒中 (AIS) 患者,再灌注是临床结局的关键因素。然而,关于从发病到再灌注结果之间的时间与再灌注结果之间的关联的数据很少。
分析 AIS 患者在发病后不同时间开始 EVT 治疗后的再灌注率。
设计、地点和参与者:我们对高效再灌注使用多种血管内装置(HERMES)组的 7 项随机试验的个体患者数据进行了荟萃分析。这是 HERMES 组中随机临床试验干预臂的多中心队列研究。纳入接受 EVT 治疗 M1/M2 或颅内颈内动脉闭塞的前循环 AIS 患者。每个试验都根据其具体的纳入和排除标准纳入患者。符合条件但未纳入的患者的数据(例如,拒绝或排除)不可用。所有分析均由 HERMES 生物统计学核心实验室使用合并数据库进行。数据于 2010 年 12 月至 2015 年 4 月进行分析。
成功再灌注定义为调整年龄、闭塞部位、治疗前静脉溶栓、血栓负荷评分后的改良脑梗死溶栓评分 2b/3,并与不同时间(发病、急诊就诊、影像学和穿刺)相关,采用混合方法逻辑回归进行分析。
在 728 名纳入患者中,平均(SD)年龄为 65.4(13.5)岁,其中 345 名为女性(47.4%),随着从入院到腹股沟穿刺的时间增加,定义为脑梗死溶栓评分 2b/3 的成功再灌注率呈下降趋势。每增加一个小时,效果幅度为相对减少 22%(比值比,0.78;95%置信区间,0.64-0.95),从影像学到穿刺每增加一个小时,相对减少 26%(比值比,0.74;95%置信区间,0.59-0.93)。
由于从到达医院到腹股沟穿刺之间的时间与再灌注概率显著降低,因此我们为缩短前循环急性缺血性脑卒中发病后的时间间隔提供了额外的论据。